GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Medidata Solutions Inc (NAS:MDSO) » Definitions » Intrinsic Value: Projected FCF

Medidata Solutions (Medidata Solutions) Intrinsic Value: Projected FCF : $0.00 (As of May. 06, 2024)


View and export this data going back to 2009. Start your Free Trial

What is Medidata Solutions Intrinsic Value: Projected FCF?

Since the intrinsic value calculations based on Discounted Cash Flow Intrinsic Value: DCF (FCF Based), or Discounted Earnings Intrinsic Value: DCF (Earnings Based) cannot be applied to companies without consistent revenue and earnings, GuruFocus developed a valuation model based on normalized Free Cash Flow and Book Value of the company. The details of how we calculate the intrinsic value of stocks are described in detail here.

As of today (2024-05-06), Medidata Solutions's Intrinsic Value: Projected FCF is $0.00. The stock price of Medidata Solutions is $92.22. Therefore, Medidata Solutions's Price-to-Intrinsic-Value-Projected-FCF of today is 0.0.

The historical rank and industry rank for Medidata Solutions's Intrinsic Value: Projected FCF or its related term are showing as below:

MDSO's Price-to-Projected-FCF is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 1.285
* Ranked among companies with meaningful Price-to-Projected-FCF only.

Medidata Solutions Intrinsic Value: Projected FCF Historical Data

The historical data trend for Medidata Solutions's Intrinsic Value: Projected FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medidata Solutions Intrinsic Value: Projected FCF Chart

Medidata Solutions Annual Data
Trend Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18
Intrinsic Value: Projected FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 8.95 11.39 16.68 19.53 22.25

Medidata Solutions Quarterly Data
Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19
Intrinsic Value: Projected FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 19.88 20.69 22.25 21.77 21.37

Competitive Comparison of Medidata Solutions's Intrinsic Value: Projected FCF

For the Health Information Services subindustry, Medidata Solutions's Price-to-Projected-FCF, along with its competitors' market caps and Price-to-Projected-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medidata Solutions's Price-to-Projected-FCF Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Medidata Solutions's Price-to-Projected-FCF distribution charts can be found below:

* The bar in red indicates where Medidata Solutions's Price-to-Projected-FCF falls into.



Medidata Solutions Intrinsic Value: Projected FCF Calculation

Since the intrinsic value calculations based on Discounted Cash Flow Intrinsic Value: DCF (FCF Based), or Discounted Earnings Intrinsic Value: DCF (Earnings Based) cannot be applied to companies without consistent revenue and earnings, GuruFocus developed a valuation model based on normalized Free Cash Flow and Book Value of the company.

The details of how we calculate the intrinsic value of stocks are described in detail here.

This method smooths out the free cash flow over the past 6-7 years, multiplies the results by a growth multiple, and adds a portion of Total Stockholders Equity.

Intrinsic Value: Projected FCF = ( Growth Multiple * Free Cash Flow (6 year avg) + 0.8 * Total Stockholders Equity (most recent) ) / Shares Outstanding (Diluted Average)

In the case of negative Total Stockholders Equity, the following formula is used (see Explanation section below for the reason):

Intrinsic Value: Projected FCF = ( Growth Multiple * Free Cash Flow (6 year avg) + Total Stockholders Equity (most recent) / 0.8 ) / Shares Outstanding (Diluted Average)


Add all the Free Cash Flow together and divide 6 will get Medidata Solutions's Free Cash Flow(6 year avg) = $55.54.

Medidata Solutions's Intrinsic Value: Projected FCF for today is calculated as

Intrinsic Value: Projected FCF=(Growth Multiple*Free Cash Flow (6 year avg)+Total Stockholders Equity (Jun19)*0.8)/Shares Outstanding (Diluted Average)
=(14.862653310476*55.53952+660.459*0.8)/62.372
=21.71

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Medidata Solutions  (NAS:MDSO) Intrinsic Value: Projected FCF Explanation

The growth multiple is capped between 8.35 and 17.74.

Total Stockholders Equity weighting is more art than science and it should always be revisited in more detail when researching a company. Weightings from 0% to 100% to more than 100% are possible. 80% was chosen as a happy median after taking the above ideas into consideration.

Medidata Solutions's Price-to-Intrinsic-Value-Projected-FCF for today is calculated as

Price-to-Intrinsic-Value-Projected-FCF=Share Price/Intrinsic Value: Projected FCF
=92.22/21.705762694642
=4.25

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Medidata Solutions Intrinsic Value: Projected FCF Related Terms

Thank you for viewing the detailed overview of Medidata Solutions's Intrinsic Value: Projected FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Medidata Solutions (Medidata Solutions) Business Description

Traded in Other Exchanges
N/A
Address
350 Hudson Street, 9th Floor, New York, NY, USA, 10014
Medidata Solutions Inc provides cloud-based solutions for the clinical development programs of life sciences companies. Its customers include biopharmaceutical companies, device makers, contract research organizations, and academic institutions. The majority of the company's business comes from subscriptions to the Medidata Clinical Cloud, with the remainder of revenue coming from services. The Medidata Clinical Cloud provides solutions for study design and planning, data capture, patient activity measurement, risk-based monitoring, and payments. The services segment includes technology and support services and professional consulting services. The majority of the firm's revenue is generated within the United States.
Executives
Carlos Dominguez director C/O MEDIDATA SOLUTIONS, INC., 79 FIFTH AVENUE, 8TH FLOOR, NEW YORK NY 10003
Lee Shapiro director C/O ALLSCRIPTS HEALTCHARE SOLUTIONS, 2401 COMMERCE DR, LIBERTYVILLE IL 60048
Michael L Capone officer: Chief Operating Officer C/O DYNATRACE HOLDINGS LLC, 1601 TRAPELO ROAD, SUITE 116, WALTHAM MA 02451
Eileen Schloss officer: OUTGOING EVP, HUMAN RESOURCES C/O MEDIDATA SOLUTIONS, INC., 79 FIFTH AVENUE, 8TH FLOOR, NEW YORK NY 10003
Alan Mateo officer: EVP, Field Operations C/O VEEVA SYSTEMS, 4280 HACIENDA DRIVE, PLEASANTON CA 94588
Insight Holdings Group, Llc 10 percent owner 1114 AVENUE OF THE AMERICAS, 36TH FLOOR, NEW YORK NY 10036

Medidata Solutions (Medidata Solutions) Headlines

From GuruFocus

Medidata Solutions Inc. (MDSO) Chairman & CEO Tarek Sherif sells 3,000 Shares

By GuruFocus Research GuruFocus Editor 02-03-2011

There's More In The Clouds At Medidata Than Just The Valuation

By Ken McGaha Ken McGaha 07-21-2015

Columbia Wanger's Largest Trades in 3rd Quarter

By Tiziano Frateschi Tiziano Frateschi 11-11-2016